Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis
NCT06551402
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Cerebral Venous Sinus Thrombosis
Interventions
DRUG:
Dabigatran Etexilate 150mg
DRUG:
Rivaroxaban 20 MG Oral Tablet
Sponsor
Kafrelsheikh University